Senate Hearing on Opioid Epidemic Focuses on Limiting Multiple Access…
The Senate Finance Committee held a hearing focused on the opioid abuse epidemic and its effect on the Medicare system.…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Robert Califf Confirmed as FDA Commissioner 89-4
Despite months of hand-wringing and opposition, the Senate overwhelmingly voted to confirm Dr. Robert Califf as the next Food and…
Responsibility in Drug Advertising Act of 2016 – Introduced to…
United States House of Representatives member Rosa DeLauro introduced a bill the Responsibility in Drug Advertising Act …
Virginia: The Latest (Failed) Attempt at Mandating Drug Pricing…
Virginia has joined the list of states with failed attempts at drug price transparency legislation in various states, as…
Pfizer Reaches “Agreement in Principle” for Wyeth Whistleblower Case for…
Pfizer and the United States government reached an "agreement in principle" on February 16, 2016 regarding two…
White House Budget includes Prescription Drug Cost Provisions and Publish…
Recently, the White House released its 2017 Budget through the Office of Management and Budget (OMB). In the Budget, the…
2016 The Year of Pharmacy Enforcement
For some time now, both the U.S. Department of Justice ("DOJ") and the Drug Enforcement Administration ("DEA") have…
Understanding Medicare Access and CHIP Reauthorization Act of 2015 (MACRA),…
Last year Congress and President Obama approved a bipartisan bill for United States healthcare reform, the bill known as…
Open Payments 2016 Updates: Companies Should Report Retired and Deceased…
In politics it is sometimes noted that death does not necessarily prevent you from voting, in the case of Open Payments…
Congress Seeks Feedback on Site-Neutral Provision of Bipartisan Budget Act…
House Energy and Commerce Committee Chairman, Representative Fred Upton, and Subcommittee on Health Chairman,…